Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock

Summary

The purpose of this trial is to investigate the potential of FE 202158 as a treatment which can stabilize blood pressure for treatment of patients in early septic shock.

Timeline

Start

2012-06

Primary completion

2013-11

Completion

2013-11

Drugs

Indications